Myo®broblasts are ®broblasts that express certain features of smooth muscle differentiation. Increased numbers of myo®broblasts and mast cells are frequently found together in a wide variety of settings, such as normal wound repair and scleroderma skin, which suggests that mediators produced by the mast cells could play a role in the regulation of myo®bro-blast differentiation and function. We used a human mast cell line, HMC-1, to determine if mast cells can induce normal human dermal ®broblasts to differentiate into functional myo®broblasts in vitro. We monitored the differentiation process by assaying two properties of the myo®broblast phenotype: expression of a-smooth muscle actin and functional capacity to contract a collagen matrix. In both a simple coculture system and in a skin-equivalent culture system, HMC-1 cells induced a-smooth muscle actin expression by ®broblasts. HMC-1 cells also stimulated ®broblast contraction of collagen gels, and the relative amount of contraction was dependent upon the number of HMC-1 cells present. To characterize the individual contributions made by speci®c mast cell products, we examined the effects of histamine, tumor necrosis factor a, and tryptase. Histamine induced a clear increase in asmooth muscle actin expression, but it did not appear to stimulate ®broblast contraction. Tumor necrosis factor a had no effect in either assay. Puri®ed human tryptase induced a-smooth muscle actin expression, and blocking the proteolytic activity of tryptase with speci®c inhibitors reduced that response. Tryptase inhibitors also eliminated the ability of HMC-1 cells to stimulate ®broblast contraction, suggesting that tryptase secreted by the HMC-1 cells may be one of the active mast cell mediators. Key words: a-actin/collagen/histamine/transforming growth factor b/tryptase.
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Perhaps the most critical event in the normal process of wound repair and in the evolution of ®brosis is the appearance of activated myo®broblasts (Powell et al, 1999) . These cells can apparently originate from several different sources, and a number of different activating factors may be involved. Mast cells are a potential source of some of those factors. One remarkably consistent ®nding is that myo®broblasts arise in a wide variety of settings concurrently with a local increase in the number of tissue mast cells (Choi and Claman, 1987; Rothe and Kerdel, 1991; Hebda et al, 1993) . The concept that biologically signi®cant interactions occur between mast cells and ®broblasts is supported by the fact that numerous mediators produced by mast cells, such as histamine, tumor necrosis factor a (TNF-a), and tryptase, can in¯uence ®broblast development, proliferation, and behavior. Tryptase, for example, is a serine protease unique to mast cells, and it can stimulate ®broblast proliferation (Ruoss et al, 1991; Hartmann et al, 1992; Abe et al, 1998) and collagen synthesis (Cairns and Walls, 1997; Gruber et al, 1997; Abe et al, 1998) . As mast cells have such pleiotropic effects on ®broblasts, we explored the possibility that speci®c mast cell products might be able to induce normal human dermal ®broblasts to differentiate into functional myo®broblasts.
MATERIALS AND METHODS
Cell culture Several different ®broblast cultures were used over the course of this work. One culture of normal human ®broblasts isolated from foreskin, AG01523C, was obtained from the National Institute on Aging, Aging Cell Culture Repository, Coriell Institute for Medical Research (Camden, NJ). These cells were fed minimum essential medium containing Earle's salts, and 26 mM sodium bicarbonate, 25 mM HEPES, pH 7.3 (catalog #42360, Life Technologies, Gaithersburg, MD), supplemented with nonessential amino acids (#11140, Life Technologies), 10% fetal bovine serum (HyClone Laboratories, Logan, UT), 100 U per ml penicillin and 100 mg per ml streptomycin. Three other cultures of foreskin ®broblasts were prepared in this laboratory from enzyme-digested tissue. These cultures were fed Dulbecco's modi®ed Eagle's medium (DMEM; #12100, Life Technologies), supplemented with 44 mM sodium bicarbonate, 1 mM sodium pyruvate, 10% heat-inactivated fetal bovine serum, 100 U per ml penicillin, 100 mg per ml streptomycin, and 250 ng per ml fungizone (Life Technologies). All ®broblast cultures were maintained in an atmosphere of 5% CO 2 at 37°C.
The human mast cell line, HMC-1 (Butter®eld et al, 1988) , was obtained from J. H. Butter®eld (Mayo Clinic, Rochester, MN) . Cultures of HMC-1 cells were grown at 37°C, 5% CO 2 , in Iscove's modi®ed Dulbecco's medium (IMDM; catalog #12200, Life Technologies), supplemented with 36 mM sodium bicarbonate, 1.2 mM monothioglycerol (Sigma-Aldrich, St. Louis, MO), 10% heat-inactivated fetal bovine serum, 100 U per ml penicillin, 100 mg per ml streptomycin, and 250 ng per ml fungizone.
A freeze/thaw lysate of HMC-1 cells was prepared by the following procedure. HMC-1 cells were washed once with IMDM supplemented only with 36 mM sodium bicarbonate, resuspended in the same medium at a concentration of 5 Q 10 6 cells per ml, and then sequentially frozen and thawed ®ve times. Finally, the cell lysate was clari®ed by centrifugation to remove cell debris. The concentration of total protein in a typical lysate preparation was »0.5 mg per ml, as measured in the BCA protein assay (Pierce, Rockford, IL).
Organotypic skin cultures were prepared as described previously (Garlick and Taichman, 1994b; Gruber et al, 1997) . The culture system used here consisted of a collagen gel matrix, containing human foreskin ®broblasts and human dermal microvascular endothelial cells, supporting a strati®ed layer of human foreskin keratinocytes. In some cases, HMC-1 cells were also embedded in the collagen gel. Organotypic cultures, or rafts, were grown submerged for 5 d and then raised to the air interface for another 5 d to allow for complete strati®cation and differentiation of surface keratinocytes. We have used this skin-equivalent culture system previously to study interactions between mast cells and dermal ®broblasts (Meng et al, 1995; Gruber et al, 1997) because it manifests epithelial strati®cation and other properties of living skin (Garlick and Taichman, 1994a, b) .
Transforming growth factor b1 (TGF-b1) puri®ed from human platelets, recombinant human platelet-derived growth factor BB (PDGF-BB), and recombinant human TNF-a were purchased from R&D Systems. Histamine (#H-7375) was purchased from Sigma-Aldrich.
Immunohistochemistry Normal human foreskin ®broblasts (10 5 cells) were grown for 24 h on glass coverslips (18 mm Q 18 mm) in complete medium containing serum, and then HMC-1 cells (10 6 cells) or TGF-b1 (5 ng per ml) was added to some of the coverslips and cultures were continued for an additional 48 h. The coverslips were washed once gently with phosphate-buffered saline (PBS) before the cells were ®xed with ice-cold acetone for 15 min. The ®xed cells were washed three times with PBS containing 0.05% Tween 20 (PBS/T) and then stained with a mouse monoclonal antibody speci®c for a-smooth muscle actin, clone 1A4 from Sigma-Aldrich, followed by¯uorescein isthiocyanate conjugated goat antimouse IgG. To identify and locate mast cells, coverslips to which HMC-1 cells had been added were stained a second time using a monoclonal antibody against human tryptase (clone B2 from L.B. Schwartz, Virginia Commonwealth University, Richmond, VA) followed by a TRITC conjugate.
Organotypic cultures containing ®broblasts and HMC-1 cells, or ®broblasts without HMC-1 cells, were prepared and grown in complete medium as described above. Paraf®n-embedded sections from individual rafts were deparaf®nized, rehydrated with PBS, ®xed in acetone, blocked for 60 min with 1% nonfat milk in PBS, and then incubated with the 1A4 anti-a smooth muscle actin monoclonal antibody for 60 min at room temperature. After sections were washed three times with PBS, they were incubated with biotinylated horse antimouse IgG for 30 min. The slides were again washed before incubation with streptavidin± alkaline phosphatase conjugate for 30 min. After three more washes, the slides were developed with fast red substrate (BioGenex, San Ramon, CA), and then counterstained with hematoxylin. To quantitate the results of the staining, we counted the number of positive cells within a de®ned area (450 mm Q 150 mm) on three different sections from each raft.
Collagen contraction assay This assay was adapted from a published protocol (Greiling and Clark, 1997) . Fibroblast cultures at 80% con¯uence were harvested by treatment with 0.05% trypsin/0.02% ethylenediamine tetraacetic acid (Clonetics, Walkersville, MD). Trypsin was inactivated with trypsin neutralizing solution (Clonetics). The cells were resuspended in DMEM containing 2% bovine serum albumin (BSA) (DMEM/BSA) at a concentration of 1 Q 10 6 cells per ml. The ®broblast suspension was mixed with neutralized collagen (Vitrogen 100, Celtrix Laboratories, Santa Clara, CA), 5 Q concentrated DMEM, and sodium bicarbonate, and, in certain experiments, HMC-1 cells. The ®nal volume was adjusted so that DMEM and sodium bicarbonate were present at normal strength and the concentration of collagen was 1.8 mg per ml. The number of ®broblasts in the ®nal mixture was kept constant at 500,000 ®broblasts per ml. In certain experiments, the mixture also contained from 20,000 to 500,000 HMC-1 cells per ml. Aliquots (0.5 ml) of the cell mixture were added to wells of a 24-well tissue culture plate, which had been coated with 2% BSA, and the collagen was allowed to polymerize at 37°C. After a 2 h incubation, the round gels were gently detached from the plastic surface to allow contraction, 0.5 ml DMEM/BSA was added to each well, and the gels were incubated at 37°C for 1±72 h. The DMEM/BSA fed to the cells at this point, when speci®ed, contained fetal bovine serum (10%), PDGF-BB (5 ng per ml), TGF-b1 (5 ng per ml), histamine (0.5±5 mg per ml), or TNF-a (10±100 ng per ml). It is important to emphasize that the DMEM/BSA medium used for the preparation and incubation of collagen gels did not routinely contain serum; serum was present, to stimulate contraction, only when speci®ed. The amount of contraction was assessed by measuring collagen gel diameter after incubation for the indicated time, usually 72 h. The results presented here are expressed as a percentage of the contraction stimulated by PDGF-BB, which was used at the optimal dose established in preliminary experiments. Stimulation with PDGF-BB for 72 h typically caused the ®broblasts to contract the collagen gels to 50% or less of the size of control, unstimulated gels. Collagen gel contraction in all of these experiments was completely dependent upon the presence of ®broblasts. Gels prepared without cells, or with only HMC-1 cells, did not contract (data not shown).
Tryptase inhibitors were tested by adding the inhibitors to the HMC-1 cell suspension (500,000 cells per ml) before the HMC-1 cells were mixed with the ®broblasts and collagen solution as described above. Bis(5-amidino-2-benzimidazolyl)methane (BABIM) was kindly provided by R. Tidwell (University of North Carolina, Chapel Hill, NC). Recombinant leech-derived tryptase inhibitor (rLDTI) was a generous gift from C. P. Sommerhof (Abteilung fu Èr Klinische Chemie und Klinische Biochemie in der Chirurgischen Klinik und Poliklinik, Mu Ènchen, Germany). BABIM (Caughey et al, 1993) and rLDTI (Sommerhoff et al, 1994) are both speci®c inhibitors of tryptase proteolytic activity. The general protocol described above was modi®ed slightly to measure the effect of HMC-1 cells on ®broblast contraction when the HMC-1 cells were cocultured with the ®broblast, but were not incorporated into the collagen gel. In those experiments, the porous membrane of a cell culture insert (catalog #3401, Corning Costar, Cambridge, MA) was used to separate the HMC-1 cells from the collagen gel, which contained only ®broblasts. The cup-shaped inserts were carefully positioned a few millimeters above the collagen gels, and 0.5 ml aliquots of the HMC-1 cell suspension (500,000 cells per ml) were dispensed directly into the inserts. Subsequent steps followed the standard protocol.
Gel electrophoresis and immunoblotting Normal human dermal ®broblasts were seeded into six-well plates, 100,000 cells per well, and fed culture medium fully supplemented with serum and the other components listed above. After 24 h, cells were washed twice with PBS and fed serum-free medium containing 2 mg per ml BSA (SFA). After another 24 h, cells were washed twice with PBS, and then either treated as described below or fed SFA containing the speci®ed additions and incubated for 72 h. Finally, the wells were washed three times with PBS and the cells in each well were lysed with 0.1 ml of Tris-buffered saline containing 1% sodium dodecyl sulfate (SDS) and protease inhibitors. The protein concentration in each sample was determined with the BCA protein assay using the supplied BSA as a standard. Equal amounts of protein from each sample, typically 1±10 mg, were separated under reducing conditions on a 10% Tris-HCl Ready Gel (Bio-Rad Laboratories, Hercules, CA) in SDS running buffer, and then the proteins were electrophoretically transferred to Immobilon-P membrane (Millipore, Bedford, MA). The membrane blot was blocked with 1% nonfat milk in PBS/T and then incubated with the 1A4 anti-a smooth muscle actin monoclonal antibody, followed sequentially by biotinylated antimouse IgG (Vector Laboratories, Burlingame, CA) and alkaline phosphatase±streptavidin conjugate (Vector). After these incubations, the immunoblot was stained using BCIP/NBT substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) and the stained immunoblot was quantitated using NIH Image.
In certain experiments, ®broblast cultures were treated with tryptase immediately before the 72 h incubation in SFA medium. Tryptase solutions of 1±10 nM were prepared in SFA adjusted to pH 6.5 (Ren et al, 1997 (Ren et al, , 1998 . Aliquots of these solutions were incubated at ambient temperature for 60 min with no additions, with 4-(2-aminoethyl)-benzenesulfonyl¯uoride hydrochloride (AEBSF Pefabloc SC; 2 mM), or with a combination of soybean trypsin inhibitor (10 mg per ml) and aprotinin (2 mg per ml). These three different tryptase solutions were then applied to ®broblast cultures prepared as described above. The cultures were incubated for 30 min at 37°C, washed twice with PBS, and ®nally fed SFA containing the speci®ed additions and incubated for 72 h.
Puri®ed human lung tryptase, soybean trypsin inhibitor (#T-9003), and aprotinin (#A-4529) were obtained from Sigma-Aldrich. AEBSF was purchased from Roche Molecular Biochemicals (Indianapolis, IN).
RESULTS
The goal of this research was to determine if HMC-1 mast cells can induce normal human dermal ®broblasts to differentiate into functional myo®broblasts. We monitored the differentiation process by assaying two important properties of the myo®broblast phenotype: a-smooth muscle actin expression and functional capacity to contract a collagen matrix. TGF-b1 was used as a positive control in many of these experiments because it potently induces a-smooth muscle actin expression (Desmoulie Áre et al, 1993; Ronnov-Jessen and Peterson, 1993) and markedly stimulates collagen gel contraction (Montesano and Orci, 1988; Finesmith et al, 1990; Fukamizu and Grinnell, 1990) .
Fibroblast a-smooth muscle actin expression In the ®rst set of experiments normal human dermal ®broblasts were cultured on coverslips, either with or without HMC-1 cells, to determine if the presence of mast cells could induce ®broblasts to express a-smooth muscle actin. As shown in Fig 1, only a low level of a-smooth muscle actin was detected in unstimulated ®broblasts (Fig 1A) . The immuno¯uorescence is weak and comparatively diffuse. As expected, however, treating the ®broblasts with TGFb1 strongly induced a-smooth muscle actin expression (Fig 1C) . The cytoskeleton in the spindle-shaped ®broblasts is much more brightly stained and many individual actin ®laments are discernible. Notably, ®broblasts cocultured with HMC-1 cells were also strongly induced to express a-smooth muscle actin (Fig 1B) .
The effect of HMC-1 cells on a-smooth muscle actin expression by ®broblasts was also studied using an organotypic (Garlick and Taichman, 1994b) , or skin-equivalent, culture system. Using this culture system for an earlier study (Gruber et al, 1997) , we demonstrated that ®broblast synthesis of type a1(I) procollagen mRNA was substantially increased in the presence of mast cells. To determine if mast cells can also induce a-smooth muscle actin expression by ®broblasts, HMC-1 cells and normal dermal ®broblasts were cultured together in the collagen layer of the skin equivalent, and then a-smooth muscle actin expression in the ®broblasts was examined by immunostaining. Figure 2 demonstrates that the presence of HMC-1 cells in the skin-equivalent culture system greatly increased the number of ®broblasts positive for a-smooth muscle actin. The average number of positive ®broblasts was 0.52 per mm 2 for cultures containing HMC-1 cells, but only 0.28 per mm 2 for control cultures, where the staining of individual cells was also less intense.
Fibroblast collagen contraction
We next sought to determine if increased a-smooth muscle actin expression in these dermal ®broblasts was accompanied by an enhanced ability to contract a collagen matrix, an important functional property of myo®broblasts (Grinnell, 1994) . Figure 3 (A) presents results from experiments measuring the effects of different treatments upon the ability of normal human dermal ®broblasts to contract a collagen gel in vitro. Serum, PDGF-BB, and TGF-b1 all stimulated ®broblast contraction of the collagen gels, although TGF-b1 was less potent. These factors were added to the culture medium surrounding the gel. HMC-1 cells stimulated substantial ®broblast contraction when they were incorporated into the collagen gels (Fig 3A, B) , but they had no effect on contraction when they were suspended above the gel on a porous membrane (data not shown). Interestingly, the contraction responses to HMC-1 cells and TGF-b1 displayed similar kinetics. Both stimulated appreciable contraction after 2± 4 h, and nearly complete contraction after 8±10 h (Fig 3C) . There appeared to be a correlation between the number of HMC-1 cells in the collagen gel and their capacity to stimulate ®broblast contraction (Fig 3B) . Lowering the number of HMC-1 cells in the collagen gel to 40% or 20% of the number of ®broblasts produced correspondingly less contraction. When the number of HMC-1 cells was reduced to 4% of the number of ®broblasts present in the gel, no contraction was noted. One normal cell type, human microvascular endothelial cells, and two transformed cell lines, COS and HepG2, were also tested to determine if other cell types could substitute for HMC-1 mast cells. None of these cells was able to stimulate contraction (data not shown).
Effects of HMC-1 cell lysate Immunoblots were used to con®rm our observation that HMC-1 cells induce a-smooth muscle actin expression in ®broblasts, and to explore further the mechanism through which this induction occurs. Normal human dermal ®broblasts were cultured alone, or with either TGF-b1 or a lysate prepared from HMC-1 cells (described in Materials and Methods), and then the amount of a-smooth muscle actin expressed under each condition was measured by immunoblotting. Densitometry of the immunoblot shown in Fig 4 revealed that TGF-b1 induced a 7.9-fold increase in a-smooth muscle actin expression, and HMC-1 cell lysate induced a 2.7-fold increase. The average induction in four separate experiments was 4.4-fold for TGF-b1 and 2.1-fold for the HMC-1 lysate.
Initially we attempted to analyze cocultures of ®broblasts and HMC-1 cells in the immunoblotting assay, and we did detect increases in a-smooth muscle actin expression. The results demonstrated wide¯uctuations, which we believe were probably caused by the variable but signi®cant numbers of HMC-1 cells that attached to ®broblasts during coculture (Trautmann et al, 1997; 1998) and that could not be entirely removed by washing before detergent solubilization of the ®broblast monolayer. In contrast, HMC-1 cell lysate gave reproducible results in the immunoblotting assay (Fig 4) and was also active in the collagen contraction assay. The lysate induced 22%±36% of maximum contraction, which is comparable to the contraction induced by intermediate numbers of intact HMC-1 cells (Fig 3B) . Heat inactivation of the lysate completely eliminated its ability to induce a-smooth muscle actin expression and to stimulate collagen contraction (data not shown).
Effects of histamine and TNF-a
As HMC-1 cell lysate appeared to be capable of inducing important features of the myo®broblast phenotype, we examined the effects of several speci®c mast cell products that might be responsible. A number of potential mediators, including histamine (Nilsson et al, 1994; Weber et al, 1996) and TNF-a (Grabbe et al, 1994; Nilsson et al, 1994) , are produced by HMC-1 cells in vitro and by human mast cells in vivo (Metcalfe et al, 1997) . Figure 5 compares the effects of TGF-b1, histamine, and TNF-a on the expression of a-smooth muscle actin by human dermal ®broblasts. Although less potent than TGF-b1, histamine also stimulated an increase in a-smooth muscle actin expression. The average induction in three separate experiments was 1.9-fold after treatment with 5 mg per ml histamine. Unlike TGF-b1, however, histamine does not appear to stimulate ®broblast contraction in the collagen contraction assay. Incubation with 0.5±5 mg per ml histamine did not stimulate ®broblast contraction (data not shown). Incubation with H1 or H2 histamine receptor antagonists, to block the effects of histamine released by HMC-1 cells, did not inhibit the contraction stimulated by HMC-1 cells (data not shown). TNF-a had no signi®cant effect on expression of a-smooth muscle actin (Fig 5) or on collagen contraction (data not shown).
Effects of tryptase
The serine protease tryptase is another mast cell mediator produced by HMC-1 cells (Butter®eld et al, 1990; Nilsson et al, 1994; Xia et al, 1995) . We took several different approaches to determine if tryptase can modulate the myo®broblast phenotype. First, we used speci®c inhibitors of the enzymatic activity of tryptase to determine if tryptase released by HMC-1 cells contributes to the collagen contraction induced by HMC-1 cells. When either BABIM (50 nM) or rLDTI (25 mM) was added to collagen gels containing ®broblasts and HMC-1 cells, contraction was only 0%±14% of maximum under conditions where contraction in the absence of inhibitors was 50%±60% of maximum. Neither tryptase inhibitor affected the contraction response to PDGF-BB. Second, we tested puri®ed human lung tryptase to determine if tryptase alone can induce a-smooth muscle actin expression by human dermal ®broblasts. As shown in Fig 6 , a brief treatment with tryptase produced a clear increase in the expression of a-smooth muscle actin by human dermal ®broblasts. Furthermore, the induction produced by tryptase appeared to require its enzymatic activity because that effect was blocked substantially by pretreatment with AEBSF, an irreversible inhibitor of serine proteases, but not by incubation with the combination of soybean trypsin inhibitor and aprotinin, both of which inhibit most serine proteases except tryptase (Alter et al, 1990; Butter®eld et al, 1990; Schwartz, 1994) .
DISCUSSION
Myo®broblasts play a central role in the normal process of wound repair and in the dysregulated processes leading to ®brosis. As the appearance of myo®broblasts often coincides with the presence of mast cells, it seems quite likely that mediators produced by mast cells are important for controlling the development and function of myo®broblasts. We used the HMC-1 human mast cell line as an experimental tool in an attempt to identify speci®c mast cell products capable of inducing two particular features of the myo®broblast phenotype. Histamine and tryptase, and the HMC-1 cells, induced normal human dermal ®broblasts to express a-smooth muscle actin, one distinguishing characteristic of differentiated myo®broblasts. Tryptase and HMC-1 cells also stimulated ®broblast contraction of a collagen matrix, one important function of myo®broblasts. Other myo®broblast functions, such as matrix deposition (Gruber et al, 1997) and matrix remodeling (Gruber et al, 1989) , may be subject to regulation by tryptase as well.
In some situations mast cells communicate with ®broblasts through intimate physical contacts (Greenberg and Burnstock, 1983; Heard et al, 1992; Levi-Schaffer, 1995; Trautmann et al, 1997) . One recent study (Yamamoto et al, 2000) concluded that mast cells enhance ®broblast contraction of collagen lattices partly by direct cell±cell interactions involving the c-kit receptor and the c-kit ligand, also known as stem cell factor. The collagen gels used in that study typically contained ®broblasts and HMC-1 cells at a ratio of 1:5. Although we would expect those conditions to promote more cell±cell interactions than the 1:1 ratio used in our assay, we did observe that embedding HMC-1 cells in the collagen gel stimulated contraction more effectively than simply adding any single soluble mast cell product to the culture medium, which does suggest that physical contact between the HMC-1 cells and the ®broblasts may contribute to the stimulatory signal. Close interactions do not appear to be an indispensable part of the signaling process, however. Soluble factors present in an HMC-1 cell lysate, as well as puri®ed histamine and tryptase, had clear positive effects on a-smooth muscle expression and collagen contraction. At least some of the active factors in the cell lysate were sensitive to heat, indicating that labile proteins such as tryptase might be involved.
Mast cells produce an array of pharmacologically potent molecules affecting an astonishing number of biologic events, including the differentiation and function of myo®broblasts. Histamine (Nilsson et al, 1994; Weber et al, 1996) , TNF-a (Grabbe et al, 1994; Nilsson et al, 1994) , and heparin (Nilsson et al, 1994) are produced by HMC-1 cells in vitro and by human mast cells in vivo (Metcalfe et al, 1997) . Histamine is a potent stimulus for smooth muscle contraction, but in our collagen gel assay it did not Figure 3 . Collagen contraction assay. All of the collagen gels used in these experiments contained a constant number of human dermal ®broblasts (250,000 cells per gel), and some of the gels also contained the indicated number of HMC-1 cells. (A) Fetal bovine serum (10%), PDGF-BB (5 ng per ml), and TGF-b1 (5 ng per ml) were added separately to collagen gels containing only ®broblasts. Collagen gels containing both ®broblasts and HMC-1 cells (250,000 cells per gel) did not receive any additional stimulus. All gels were incubated for 72 h before measurement. The results are expressed as a percentage of the contraction stimulated by PDGF-BB, which was assigned the maximum value of 100%. The data shown are means and SEM from seven independent experiments with n = 16. Compared to control gels, p = 0.00025 for all four stimuli. (B) Contraction was stimulated, as described above, by PDGF-BB (5 ng per ml), TGF-b1 (5 ng per ml), or a varying number of HMC-1 cells (from 10,000 to 250,000 cells per gel) within the gel. Results are again expressed as a percentage of the maximum contraction stimulated by PDGF-BB. The data shown are the means and standard deviations from four independent experiments with n = 10. (C) Kinetics of contraction stimulated by PDGF-BB (5 ng per ml), TGF-b1 (5 ng per ml), or HMC-1 cells (250,000 cells per gel). The amount of contraction was measured at 1 h intervals, and the results at each time point are expressed as a percentage of the contraction stimulated by PDGF-BB after 72 h.
reproducibly stimulate ®broblast contraction. In one earlier study using a similar assay, histamine did appear to stimulate ®broblast contraction, although it was relatively weak compared to PDGF (Clark et al, 1989) . Consequently, it is still not clear whether or not histamine plays a direct role in regulating myo®broblast function. Nonetheless, we did observe that histamine could induce a-smooth muscle actin expression (Fig 5) , suggesting that histamine may play a role in regulating myo®broblast differentiation. Histamine also seems to be involved in modulating several other processes intrinsic to wound repair and ®brosis, including ®broblast migration (Kupietzky and Levi-Schaffer, 1996) and production of cytokines (Zheng et al, 1994) . TNF-a, in contrast to histamine, did not affect either myo®broblast function or differentiation. We found no indication that TNF-a by itself is a suf®cient stimulus for induction of a-smooth muscle actin. It has been proposed, however, that TNF-a can facilitate the mechanism through which heparin stimulates expression of a-smooth muscle actin (Desmoulie Áre et al, 1992; Schmitt-Gra Èff et al, 1994). Heparin and TNF-a are both constituents of the granules of human tissue mast cells. TGF-b is generally considered to be crucial for the regulation of myo®bro-blast development and behavior in tissue (Powell et al, 1999; Serini and Gabbiani, 1999 ), but we have been unable to demonstrate a critical role for TGF-b in the HMC-1 cell coculture systems.
Our last set of experiments provided evidence of a surprising new role for tryptase. Previous reports investigated the effects of tryptase on ®broblast proliferation (Ruoss et al, 1991; Hartmann et al, 1992; Abe et al, 1998) and collagen synthesis (Cairns and Walls, 1997; Gruber et al, 1997; Abe et al, 1998) , and more recent studies focused on tryptase activation of PAR-1 and PAR-2 (Corvera et al, 1997; Mirza et al, 1997; Molino et al, 1997; Schechter et al, 1998; Akers et al, 2000) . We are not aware of any studies published to date that speci®cally address tryptase regulation of myo®broblast differentiation or function. Nonetheless, there have been a number of relevant studies on thrombin stimulation of ®broblast contraction in a collagen matrix (Kolodney and Wysolmerski, 1992; Kolodney and Elson, 1993; Pilcher et al, 1994; 1995) , and there may be some common elements in mechanisms through which tryptase and thrombin stimulate contraction. One common feature, the requirement for enzymatic activity, suggests that thrombin and tryptase may be signaling through members of the family of protease-activated receptors known as PARs (De Âry et al, 1998) . In fact, there is published evidence that thrombin stimulates ®broblast contraction through PAR-1 (Pilcher et al, 1994; 1995) , and we have preliminary data suggesting that tryptase may be signaling through PAR-2. Immunoblot showing the effect of puri®ed human tryptase on a-smooth muscle actin expression by human dermal ®broblasts. Fibroblast cultures were treated for 30 min with serum-free medium, pH 6.5, without (±) or with (+) the addition of 10 nM puri®ed human tryptase and the indicated protease inhibitors as described in Materials and Methods. After 72 h ®broblasts were analyzed for asmooth muscle actin expression. Immunoblot demonstrating that mast cell products induce ®broblast expression of a-smooth muscle actin. Normal human dermal ®broblasts were cultured for 72 h in serum-free medium (control) or in serum-free medium containing TGF-b1 (5 ng per ml) or HMC-1 cell lysate (diluted 1:10). Equal amounts of protein from different cultures were examined on immunoblots using the 1A4 monoclonal antibody speci®c for a-smooth muscle actin. TGF-b1 was used here as a positive control for induction of a-smooth muscle actin. Figure 5 . Immunoblot comparing effects of TGF-b1, histamine, and TNF-a on a-smooth muscle actin expression by human dermal ®broblasts. Foreskin ®broblasts were cultured for 72 h in serum-free medium (C, control) or in serum-free medium containing TNF-a (10±100 ng per ml), histamine (0.1±30.0 mg per ml), or TGF-b1 (5 ng per ml).
